SCHEMBL23157106

SCHEMBL23157106

CSS[C@H](CN=N)C[C@H](NC(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CTSK P43235 6/20 0.38
▸ CTSS P25774 5/20 0.38
▸ CTSL P07711 2/20 0.37
▸ CTSB P07858 1/20 0.37
▸ PPARG P37231 6/20 0.36
▸ PPARA Q07869 6/20 0.36
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA7 P43166 1/20 0.35
▸ PPARD Q03181 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ CAPN1 P07384 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15083181 1.00 CYP1A2 (0.39) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL23157235 0.90 PPARA (0.43) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL15083495 0.90 PPARA (0.43) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL15083192 0.89 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL23056579 0.89 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL16310468 0.89 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL15083189 0.87 CTSS (0.42) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL16288237 0.85 CYP1A2 (0.36) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL16288233 0.85 CYP1A2 (0.36) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL16288231 0.85 CYP1A2 (0.36) CYP1A2CYP2C9CYP2C19HTTCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2813512-B1 PEPTIDE-COMPOUND CYCLIZATION METHOD CHUGAI PHARMACEUTICAL CO LTD (JP) 2021-03-31 — — EP disclosed
Send feedback